NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

SANDU PHARMACEUTICALS

BSE: 524703 22 Feb 2025
Healthcare
₹ 53.6
Sandu Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SANDU PHARMACEUTICALS - Share Price & Details

Market Cap
₹51.8
High /Low
72.5 / 49.5
Stock P/E
35.2
Book Value
₹42.3
Dividend Yield
1.49
ROCE
5.36
ROE
₹3.66
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹17.2
Debt
0.52
CMP / FCF
-111.0
Debt to equity
₹0.01
NP Ann
1.46
High price all time
86.0
Piotroski score
₹5.0
Graham Number
38.0
No. Eq. Shares
0.97
Net CF
₹-1.27
Net profit
1.47
Price to book value
1.27
Interest Coverage
₹27.4
Low price all time
6.14
Industry PE
35.4
Reserves
₹31.2
Free Cash Flow
₹-0.67

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
SANDU PHARMACEUTICALS LTD.183.730.5735.2
GUJARAT TERCE LABORATORIES LTD126.811.3617.0
Deccan Health Care Limited204.290.0642.9

Peer Comparison Chart


About SANDU PHARMACEUTICALS

Sandu Pharmaceuticals Ltd., with Security Code 524703, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Sandu Pharmaceuticals Hits 52-Week Low at Rs 52.6, Declines 25.21% Over Past Year

(16 Jan 2025)
Sandu Pharmaceuticals, a microcap company in the trading industry, has recently reached a 52-week low, closing at Rs 52.6 on January 16,...
Read more →

Sandu Pharmaceuticals Hits 52-Week Low at Rs 53.5, Down 24.80% Yearly

(13 Jan 2025)
Sandu Pharmaceuticals, a microcap company in the trading industry, has recently reached a 52-week low, closing at Rs 53.5 on January 13, 2025.
Read more →

Sandu Pharmaceuticals Hits 52-Week Low at Rs. 53.5 Amid Ongoing Decline

(10 Jan 2025)
Sandu Pharmaceuticals, a microcap company in the trading industry, has recently reached a new 52-week low, with its stock price hitting Rs.
Read more →

Sandu Pharmaceuticals Reports Positive Financial Results for Q2 2024-25

(19 Nov 2024)
Sandu Pharmaceuticals, a microcap trading company, has recently announced its financial results for the quarter ending September 2024.
Read more →

Sandu Pharmaceuticals consolidated net profit declines 9.09% in the September 2024 quarter

(15 Nov 2024)
Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter...
Read more →

Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter

(15 Nov 2024)
Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter...
Read more →